The source identifies a research collaboration involving the University of Cambridge, Storm Therapeutics, Evotech, AstraZeneca, the Wellcome Sanger Institute, Open Targets and institutions in Germany. The contributors are affiliated with stem-cell, hematology, cancer-research, genomics, pharmacy, liver and blood-transplant research groups in the UK and Germany.
Additional contributors
Eliza Yankova, Alexandra Sapetschnig and Beth Thomas also contributed.
Author affiliations
Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
Eliza Yankova, Sian Evans, Maria Eleftheriou, Malgorzata Gozdecca, Teresa Brevini, Rachel Wilson, George Ziotopoulos, Ryan Asby, Laura Bond, James Russell, Judith López-Ruiz, Giovanna Mantica, Jake Tobin, Diego López-Leon, Dee Ng C. Pasuk, Vidur Tandon, Evangelia Stamou, Maria T. Bejar, Yogeshkumar Malam, Elisa Laurenti, Huang Li, Maria P. Arcolea, Walid T. Khaled, Fotios Sampaziotis, George S. Vasiliu, Brian JP Huntley and Konstantinos Tselepis
Department of Hematology, University of Cambridge, Cambridge, UK
Eliza Jankova, Sian Evans, Maria Eleftheriou, Malgorzata Gozdetzka, Rachel Wilson, George Geotopoulos, Ryan Asby, Laura Bond, James Russell, Judith Lopez-Ruiz, Giovanna Manti Ka, Jake Tobin, Diego Lopez-Leon, Dean C. Pask, Vidur Tandon, Evangelia Stamou, Elisa Laurenti, Huang Li, George S. Vasiliu, Brian JP Huntley and Konstantinos Tselepis
Milner Therapy Institute, University of Cambridge, Cambridge, UK
Eliza Yankova, Sian Evans, Maria Eleftheriou, Judith López-Ruiz, Evangelia Stamou and Konstantinos Tselepis
Storm Therapeutics, Cambridge, UK
Alexandra Sapetunich, Beth Thomas, Harry Fischl, Sarah J. Bucknell, Carmen M. Livy, Alexandra Azevedo, Natalie Webster, Jack Logan, Byron Andrews, Hendrik Weisser, Richard Fosbaer, Sapphire Sawyer and Oliver Rausch
Evotech, Abingdon, UK
Andrew Hutchin
Cambridge Blood and Stem Cell Biobank, Department of Haematology, University of Cambridge, Cambridge, UK
Joanna Baxter
Center for Genomics Research, Discovery Sciences, Biopharmaceutical Research and Development, AstraZeneca, Cambridge, UK
Jake Tobin
Wellcome Sanger Institute, Cambridge, UK
Sunai Usluar, Nitila Joseph, David J. Adams and Konstantinos Tselepis
Open Targets, Wellcome Genome Campus, Cambridge, UK
Sunai Usulua and Nithila Joseph
University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, UK
Maria T. Bejart and Maria P. Arcolea
Institute of Molecular Oncology and Functional Genomics, Faculty of Medicine, Technical University of Munich, Munich, Germany
Roland Rudd
Translational Cancer Research Center (TranslaTUM), Faculty of Medicine, Technical University of Munich, Munich, Germany
Roland Rudd
German Cancer Consortium (DKTK), Heidelberg, Germany
Roland Rudd
Second Faculty of Medicine, Technical University of Munich, Munich, Germany
Roland Rudd
Faculty of Pharmacy, University of Cambridge, Cambridge, UK
Walid T. Khaled
Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Fotios Sampaziotis
The National Institute for Health Research Blood and Transplant Research Unit at the University of Cambridge, in collaboration with Newcastle University, affiliated with NHS Blood and Transplant, Cambridge, UK
Fotios Sampaziotis
Cambridge University School of Medicine, Cambridge, UK
Fotios Sampaziotis
Source: www.nature.com


